Offer - Urjas Oil for just ₹ 1 X
Manicarb 400 Tablet SR, a prescription drug, is manufactured in various forms such as Tablet. Mania are some of its major therapeutic uses. Secondary and off-label uses of Manicarb 400 Tablet SR have also been mentioned below.
The optimal dosage of Manicarb 400 Tablet SR is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. For detailed information on this, read through the dosage section.
Some other side effects of Manicarb 400 Tablet SR have been listed ahead. Usually, these side effects of Manicarb 400 Tablet SR go away soon, and do not persist beyond the duration of the treatment. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Manicarb 400 Tablet SR is Severe for pregnant women and Severe for women who are breastfeeding. In addition, Manicarb 400 Tablet SR's effects on the liver, heart and kidney are discussed below in the Manicarb 400 Tablet SR related warnings section.
Manicarb 400 Tablet SR can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Manicarb 400 Tablet SR in conditions like Dehydration, Diarrhea (Loose Motions), Heart Disease.
Drug interactions for Manicarb 400 Tablet SR have been reported in the medical literature. See below for a complete list.
In addition to the above precautions for Manicarb 400 Tablet SR, it is important to know that it is not safe while driving, and is not habit-forming.
Manicarb 400 Tablet SR is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
Is the use of Manicarb 400 Tablet SR safe for pregnant women?
Pregnant women may get severe side effects after taking Manicarb. If you are pregnant, do not take Manicarb without a doctor's advice.
Is the use of Manicarb 400 Tablet SR safe during breastfeeding?
Manicarb should not be taken without taking your doctor's advice, as it may have severe side effects on breastfeeding women.
What is the effect of Manicarb 400 Tablet SR on the Kidneys?
Manicarb has very mild side effects on the kidneys.
What is the effect of Manicarb 400 Tablet SR on the Liver?
Using Manicarb does not have any harmful effects on the liver.
What is the effect of Manicarb 400 Tablet SR on the Heart?
Very few cases of side effects of Manicarb on the heart have been reported.
If you are suffering from any of the following diseases, you should not take Manicarb 400 Tablet SR unless your doctor advises you to do so -
Is this Manicarb 400 Tablet SR habit forming or addictive?
Manicarb 400 Tablet SR is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
You may feel sleepy or tired after taking Manicarb 400 Tablet SR. So it is best to avoid driving.
Is it safe?
Yes, but take Manicarb 400 Tablet SR only as per medical advice.
Is it able to treat mental disorders?
Manicarb 400 Tablet SR has been seen to have positive effect on patients with mental disorders.
Interaction between Food and Manicarb 400 Tablet SR
Taking Manicarb 400 Tablet SR with food is safe.
Interaction between Alcohol and Manicarb 400 Tablet SR
Taking Manicarb 400 Tablet SR with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lithium
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 447-450
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 783-784